EE672 Cost-Effectiveness Analysis of Pembrolizumab for the Adjuvant Treatment of Patients With Renal Cell Carcinoma Who Have Undergone Nephrectomy in Greece
Abstract
Authors
N. Yfantopoulos G. Emmanouil A. Skroumpelos A. Karokis